NCT07543783
- Conditions
- Adebrelimab (SHR-1316), Adenocarcinoma, Bevacizumab, +11 more
- Locations
-
Not specified
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,072 public trials
1,188 recruiting studies
Adenocarcinoma trial results
Not yet recruiting
Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma
NCT07543510
- Conditions
- Adenocarcinoma, Atezolizumab Plus Bevacizumab, Carcinoma, +11 more
- Locations
-
Not specified
Not yet recruiting
Areola Preservation in NSM With Nipple Involvement
NCT07544134
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +14 more
- Locations
-
- The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Not yet recruiting
Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis
NCT07544121
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +28 more
- Locations
-
Not specified
Not yet recruiting
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
NCT07487402
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
NCT07537946
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not yet recruiting
Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases
NCT07537959
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not yet recruiting
Decision Aid Efficacy in Low Risk Thyroid Cancer
NCT07536412
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +13 more
- Locations
-
- University of Maryland, Baltimore Baltimore, Maryland, United States
Not yet recruiting
A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma
NCT07535840
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
Not yet recruiting
Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy
NCT07537777
- Conditions
- Adenocarcinoma, Anlotinib, Benmelstobart, +14 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China